Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome

Focus on Alternative and Complementary Therapies

Volumn 17, Issue 1, 2012, Pages 33-42

  Owen Smith, Ashli ^a   McCarty, Frances ^b   Hankerson Dyson, Dana ^c   Diclemente, Ralph ^a  

^a EMORY UNIVERSITY   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

African American; complementary and alternative medicine; HIV AIDS

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUPUNCTURE; ADULT; AFRICAN AMERICAN; ALTERNATIVE MEDICINE; AROMATHERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CHIROPRACTIC; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HERB; HUMAN; MAJOR CLINICAL STUDY; MALE; MASSAGE; MEDICAL RECORD; MEDITATION; PREVALENCE; PSYCHOLOGICAL WELL BEING; SPIRITUAL HEALING; SUPPORT GROUP; TAI CHI; THERAPY EFFECT; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; YOGA;

EID: 84857316113     PISSN: 14653753     EISSN: 20427166     Source Type: Journal    
DOI: 10.1111/j.2042-7166.2011.01140.x     Document Type: Article

References (66)

1. National Center for Complementary and Alternative Medicine. What Is Complementary and Alternative Medicine? [website]. Bethesda, MD: National Center for Complementary and Alternative Medicine, 2011. <>, accessed December 8, 2008.
2. Barnes PM, Powell-Griner E, McFann K, Nahin RL,. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343: 1-19.
3. Eisenberg DM, Davis RB, Ettner SL, et al,. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-75. (Pubitemid 28520643)
4. Kessler RC, Davis RB, Foster DF, et al,. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001; 135: 262-8. (Pubitemid 32799340)
5. Hand R,. Alternative therapies used by patients with AIDS. N Engl J Med 1989; 320: 672-3. (Pubitemid 19072482)
6. Milan FB, Arnsten JH, Klein RS, et al,. Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection. AIDS Patient Care STDS 2008; 22: 811-16.
7. Block KI, Mead MN,. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2003; 2: 247-67. (Pubitemid 37138611)
8. Escher M, Desmeules J, Giostra E, Mentha G,. Hepatitis associated with kava, a herbal remedy for anxiety. BMJ 2001; 322: 139. (Pubitemid 32116192)
9. Piscitelli SC, Burstein AH, Welden N, et al,. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002; 34: 234-8. (Pubitemid 34028358)
10. Slain D, Amsden JR, Khakoo RA, et al,. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. Pharmacotherapy 2005; 25: 165-70. (Pubitemid 40223478)
11. De Maat MM, Hoetelmans RM, Math RA, et al,. Drug interaction between St John's wort and nevirapine. AIDS 2001; 15: 420-1. (Pubitemid 32163832)
12. Piscitelli SC, Burstein AH, Chaitt D, et al,. Indinavir concentrations and St John's wort. Lancet 2000; 355: 547-8. (Pubitemid 30088677)
13. Fugh-Berman A,. Herb-drug interactions. Lancet 2000; 355: 134-8. (Pubitemid 30068565)
14. Ohnishi N, Kusuhara M, Yoshioka M, et al,. Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats. Biol Pharm Bull 2003; 26: 1315-20. (Pubitemid 41656569)
15. Gurley BJ, Gardner SF, Hubbard MA, et al,. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005; 22: 525-39. (Pubitemid 41003065)
16. Beckmann-Knopp S, Rietbrock S, Weyhenmeyer R,. Inhibitory effects of silibinin on cytochrome P-450 enzymes in human liver microsomes. J Pharmacol Toxicol 2000; 86: 250-6. (Pubitemid 30413400)
17. Furler MD, Einarson TR, Walmsley S, et al,. Use of complementary and alternative medicine by HIV-infected outpatients in Ontario, Canada. AIDS Patient Care STDS 2003; 17: 155-68. (Pubitemid 36444005)
18. Milden SP, Stokols D,. Physicians' attitudes and practices regarding complementary and alternative medicine. Behav Med 2004; 30: 73-82. (Pubitemid 40019023)
19. Glanz K, Rimer B, Lewis F,. Theory, research, and practice in health behavior and health education. In:, Glanz K, Rimer B, Lewis F, (Eds). Health Behavior and Health Education: Theory, Research and Practice. San Francisco: Jossey-Bass, 2002. pp. 22-39.
20. Fouladbakhsh J, Stommel M,. Using the behavioral model for complementary and alternative medicine: the CAM healthcare model. J Complement Integr Med 2007; 4: 1-19.
21. Andersen R, Newman JF,. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc 1973; 51: 95-124.
22. Andersen RM,. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995; 36: 1-10.
23. Lengacher CA, Bennett MP, Kipp KE, et al,. Design and testing of the use of a complementary and alternative therapies survey in women with breast cancer. Oncol Nurs Forum 2003; 30: 811-21.
24. Owen-Smith A, Sterk C, McCarty F, et al,. The development and evaluation of a complementary and alternative medicine use survey in African-Americans with Acquired Immune Deficiency Syndrome. J Altern Complement Med 2010; 16: 569-77.
25. Lubeck DP, Litwin MS, Henning JM, et al,. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am J Manag Care 2000; 6: 70-6. (Pubitemid 30051797)
26. Chesney MA, Neilands TB, Chambers DB, et al,. A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol 2006; 11: 421-37. (Pubitemid 44342742)
27. Wallston KA, Wallston BS, DeVellis R,. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr 1978; 6: 160-70.
28. Weiss BD, Mays MZ, Martz W, et al,. Quick assessment of literacy in primary care: the newest vital sign. Ann Fam Med 2005; 3: 514-22. (Pubitemid 43154837)
29. Hays RD, Cunningham WE, Sherbourne CD, et al,. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med 2000; 108: 714-22. (Pubitemid 30621459)
30. Justice AC, Holmes W, Gifford AL, et al,. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001; 54: S77-90. (Pubitemid 34013693)
31. Belsley D, Kuh E, Welsch R,. Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. New York: John Wiley & Sons, 1980.
32. Bates BR, Kissinger P, Bessinger RE,. Complementary therapy use among HIV-infected patients. AIDS Patient Care STDS 1996; 10: 32-6. (Pubitemid 26152030)
33. Burg MA, Uphold CR, Findley K, Reid K,. Complementary and alternative medicine use among HIV-infected patients attending three outpatient clinics in the Southeastern United States. Int J STD AIDS 2005; 16: 112-16. (Pubitemid 40313204)
34. Langewitz W, Ruttimann S, Laifer G, et al,. The integration of alternative treatment modalities in HIV infection-the patient's perspective. J Psychosom Res 1994; 38: 687-93. (Pubitemid 24357692)
35. Mikhail IS, DiClemente R, Person S, et al,. Association of complementary and alternative medicines with HIV clinical disease among a cohort of women living with HIV/AIDS. J Acquir Immune Defic Syndr 2004; 37: 1415-22. (Pubitemid 39435056)
36. Hasan SS, See CK, Choong CLK, et al,. Reasons, perceived efficacy and factors associated with complementary and alternative medicine use among Malaysian patients with HIV/AIDS. J Altern Complement Med 2010; 16: 1171-6.
37. Barnes PM, Bloom BS, Nahin RL,. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep 2008; 12: 1-24.
38. Brown CM, Barner JC, Richards KM, Bohman TM,. Patterns of complementary and alternative medicine use in African Americans. J Altern Complement Med 2007; 13: 751-8. (Pubitemid 47585339)
39. Hsiao AF, Wong MD, Goldstein MS, et al,. Variation in complementary and alternative medicine (CAM) use across racial/ethnic groups and the development of ethnic-specific measures of CAM use. J Altern Complement Med 2006; 12: 281-90.
40. Kronenberg F, Cushman LF, Wade CM, et al,. Race/ethnicity and women's use of complementary and alternative medicine in the United States: results of a national survey. Am J Public Health 2006; 96: 1236-42. (Pubitemid 43967849)
41. Mackenzie ER, Taylor L, Bloom BS, et al,. Ethnic minority use of complementary and alternative medicine (CAM): a national probability survey of CAM utilizers. Altern Ther Health Med 2003; 9 (4): 50-6. (Pubitemid 36818625)
42. Druss BG, Rosenheck RA,. Association between use of unconventional therapies and conventional medical services. JAMA 1999; 282: 651-6. (Pubitemid 29384153)
43. Astin JA,. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548-53. (Pubitemid 28233010)
44. Bangsberg DR, Perry S, Charlebois ED, et al,. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15: 1181-3. (Pubitemid 32549871)
45. Ladenheim D, Horn O, Werneke U, et al,. Potential health risks of complementary alternative medicines in HIV patients. HIV Med 2008; 9: 653-9.
46. Chao MT, Wade C, Kronenberg F,. Disclosure of complementary and alternative medicine to conventional medical providers: variation by race/ethnicity and type of CAM. J Natl Med Assoc 2008; 100: 1341-9.
47. Bica I, Tang AM, Skinner S, et al,. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Complement Med 2003; 9: 65-76. (Pubitemid 36292745)
48. Duggan J, Peterson WS, Schutz M, et al,. Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDS 2001; 15: 159-67. (Pubitemid 32246777)
49. London AS, Foote-Ardah CE, Fleishman JA, Shapiro MF,. Use of alternative therapists among people in care for HIV in the United States. Am J Public Health 2003; 93: 980-7. (Pubitemid 38480232)
50. Ostrow MJ, Cornelisse PG, Heath KV, et al,. Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 115-20. (Pubitemid 27328038)
51. White S, Chen J, Atchison R,. Relationship of preventive health practices and health literacy: a national study. Am J Health Behav 2008; 32: 227-42.
52. Friedman DB, Hoffman-Goetz L, Arocha JF,. Health literacy and the World Wide Web: comparing the readability of leading incident cancers on the Internet. Med Inform Internet Med 2006; 31: 67-87.
53. Vallance JK, Taylor LM, Lavallee C,. Suitability and readability assessment of educational print resources related to physical activity: implications and recommendations for practice. Patient Educ Couns 2008; 72: 342-9.
54. Cotugna N, Vickery CE, Carpenter-Haefele KM,. Evaluation of literacy level of patient education pages in health-related journals. J Community Health 2005; 30: 213-19. (Pubitemid 40362718)
55. Wilson M,. Readability and patient education materials used for low-income populations. Clin Nurse Spec 2009; 23: 33-40.
56. Dwyer JT, Salvato-Schille AM, Coulston A, et al,. The use of unconventional remedies among HIV-positive men living in California. J Assoc Nurses AIDS Care 1995; 6: 17-28.
57. Fairfield KM, Eisenberg DM, Davis RB, et al,. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998; 158: 2257-64. (Pubitemid 28512500)
58. Jernewall N, Zea MC, Reisen CA, Poppen PJ,. Complementary and alternative medicine and adherence to care among HIV-positive Latino gay and bisexual men. AIDS Care 2005; 17: 601-9. (Pubitemid 40979468)
59. Risa KJ, Nepon L, Justis JC, et al,. Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy. Int J STD AIDS 2002; 13: 706-13.
60. Charmaz K,. Good Days, Bad Days: the Self in Chronic Illness and Time. New Brunswick, NJ: Rutgers University Press, 1991.
61. Charmaz K,. The body, identity and the self. Sociol Q 1995; 36: 657-80.
62. Foote-Ardah CE,. The meaning of complementary and alternative medicine practices among people with HIV in the United States: strategies for managing everyday life. Sociol Health Illn 2003; 25: 481-500. (Pubitemid 36857525)
63. Waruru AK, Nduati R, Tylleskar T,. Audio computer-assisted self-interviewing (ACASI) may avert socially desirable responses about infant feeding in the context of HIV. BMC Med Inform Decis Mak 2005; 5: 24.
64. Fox S,. Pew Internet & American life project: health information online [online publication]. Washington, DC: Pew Internet and American Life Project, 2005. <> accessed August 24, 2011.
65. Wulfert E, Wan CK, Backus CA,. Gay men's safer sex behavior: an integration of three models. J Behav Med 1996; 19: 345-66. (Pubitemid 26256661)
66. Leonard B, Huff H, Merryweather B, et al,. Knowledge of safety and herb-drug interactions amongst HIV+ individuals: a focus group study. Can J Clin Pharmacol 2004; 11: e227-231. (Pubitemid 46333119)